SCHEMBL22019709

SCHEMBL22019709

Cc1c(C(C)C)nc2c(c1C)CCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ACHE P22303 6/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 1/20 0.38
BPTF Q12830 1/20 0.38
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
GAA P10253 2/20 0.36
PTK2B Q14289 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.34
ALDH1A1 P00352 2/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
BCHE P06276 4/20 0.33
GRIN1 Q05586 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22020790 0.83 ACHE (0.52) KDM4EACHEMEN1KMT2AMAPK1
SCHEMBL24977996 0.80 KDM4E (0.34) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL24872227 0.79 GAA (0.45) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL19523169 0.76 GAA (0.39) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL21963404 0.76 NPSR1 (0.54) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL19272311 0.75 ACHE (0.54) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL22020011 0.74 KDM4E (0.40) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL22021532 0.73 ACHE (0.58) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL28641253 0.73 NPSR1 (0.38) KDM4ENPSR1ACHEMEN1KMT2A
SCHEMBL19120846 0.73 NPC1 (0.38) KDM4ENPSR1MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154499-A1 SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-07-30 WO disclosed
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed